JP2014515011A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014515011A5 JP2014515011A5 JP2013558083A JP2013558083A JP2014515011A5 JP 2014515011 A5 JP2014515011 A5 JP 2014515011A5 JP 2013558083 A JP2013558083 A JP 2013558083A JP 2013558083 A JP2013558083 A JP 2013558083A JP 2014515011 A5 JP2014515011 A5 JP 2014515011A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- colostrum
- decreased
- fish oil
- lipoic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003247 decreasing effect Effects 0.000 claims 8
- 235000021277 colostrum Nutrition 0.000 claims 7
- 210000003022 colostrum Anatomy 0.000 claims 7
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 6
- 235000021323 fish oil Nutrition 0.000 claims 6
- 229960002663 thioctic acid Drugs 0.000 claims 6
- 241001465754 Metazoa Species 0.000 claims 5
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims 5
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 235000013305 food Nutrition 0.000 claims 5
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims 5
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims 4
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 claims 4
- 235000013477 citrulline Nutrition 0.000 claims 4
- 229960002173 citrulline Drugs 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 235000019136 lipoic acid Nutrition 0.000 claims 4
- NHZMQXZHNVQTQA-UHFFFAOYSA-N pyridoxamine Chemical compound CC1=NC=C(CO)C(CN)=C1O NHZMQXZHNVQTQA-UHFFFAOYSA-N 0.000 claims 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 4
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims 3
- 230000032683 aging Effects 0.000 claims 3
- 239000004475 Arginine Substances 0.000 claims 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 claims 2
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims 2
- 108010087806 Carnosine Proteins 0.000 claims 2
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims 2
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims 2
- 229960001138 acetylsalicylic acid Drugs 0.000 claims 2
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 claims 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 2
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims 2
- BTNNPSLJPBRMLZ-LGMDPLHJSA-N benfotiamine Chemical compound C=1C=CC=CC=1C(=O)SC(/CCOP(O)(O)=O)=C(/C)N(C=O)CC1=CN=C(C)N=C1N BTNNPSLJPBRMLZ-LGMDPLHJSA-N 0.000 claims 2
- 229960002873 benfotiamine Drugs 0.000 claims 2
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims 2
- 229940044199 carnosine Drugs 0.000 claims 2
- 230000003930 cognitive ability Effects 0.000 claims 2
- 235000015872 dietary supplement Nutrition 0.000 claims 2
- 230000036737 immune function Effects 0.000 claims 2
- 210000003205 muscle Anatomy 0.000 claims 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims 2
- 230000036542 oxidative stress Effects 0.000 claims 2
- 235000008151 pyridoxamine Nutrition 0.000 claims 2
- 239000011699 pyridoxamine Substances 0.000 claims 2
- 235000021283 resveratrol Nutrition 0.000 claims 2
- 229940016667 resveratrol Drugs 0.000 claims 2
- 229960003080 taurine Drugs 0.000 claims 2
- AAMZGHJMEQRXEG-UHFFFAOYSA-M 2-(2,3-dimethyl-1,3-thiazol-3-ium-4-yl)-1-phenylethanone;chloride Chemical compound [Cl-].C[N+]1=C(C)SC=C1CC(=O)C1=CC=CC=C1 AAMZGHJMEQRXEG-UHFFFAOYSA-M 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000019197 fats Nutrition 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 230000036421 sense of balance Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161465404P | 2011-03-18 | 2011-03-18 | |
| US61/465,404 | 2011-03-18 | ||
| PCT/US2012/028712 WO2012128982A2 (en) | 2011-03-18 | 2012-03-12 | Compositions and methods useful for ameliorating age related maladies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014515011A JP2014515011A (ja) | 2014-06-26 |
| JP2014515011A5 true JP2014515011A5 (https=) | 2015-04-30 |
Family
ID=46879965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013558083A Pending JP2014515011A (ja) | 2011-03-18 | 2012-03-12 | 加齢に伴う疾病を改善するのに有用な組成物及び方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10010566B2 (https=) |
| EP (1) | EP2685987B1 (https=) |
| JP (1) | JP2014515011A (https=) |
| CN (1) | CN104066342A (https=) |
| AU (1) | AU2012231351B2 (https=) |
| BR (1) | BR112013023770B1 (https=) |
| CA (1) | CA2830476C (https=) |
| ES (1) | ES2727043T3 (https=) |
| MX (1) | MX359453B (https=) |
| RU (1) | RU2600893C2 (https=) |
| WO (1) | WO2012128982A2 (https=) |
| ZA (1) | ZA201307770B (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2014278839B2 (en) * | 2013-06-13 | 2019-06-20 | Smartfish As | A marine oil formulation comprising reservatrol or derivatives thereof for use in treating, delaying and/or preventing Alzheimer's Desease |
| US8974832B1 (en) * | 2013-12-10 | 2015-03-10 | Lifewave, Inc. | Nutritional product composition for increasing human growth hormone and nitric oxide production |
| WO2016092479A1 (en) * | 2014-12-10 | 2016-06-16 | Subramaniam Vanangamudi Sulur | A pharmaceutical formulation comprising resveratrol, benfotiamine and pyridoxamine, a process of making it and a method of treatment using it |
| WO2016100826A1 (en) * | 2014-12-19 | 2016-06-23 | Avelis Llc | Mineral complex formulations for oral administration and methods for their use |
| US10660683B2 (en) * | 2016-05-27 | 2020-05-26 | In2Bones Usa, Llc | Method for sterile packaging of K-wire and cap |
| JP2019518744A (ja) * | 2016-05-27 | 2019-07-04 | ネステク ソシエテ アノニム | 運動障害を治療又は予防するための栄養組成物 |
| WO2018066394A1 (ja) * | 2016-10-04 | 2018-04-12 | 日本水産株式会社 | 筋肉を柔軟にするための組成物 |
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| CN110381935A (zh) * | 2017-04-11 | 2019-10-25 | 雀巢产品有限公司 | 用于识别和减轻个体的认知衰老的ω-3脂肪酸和维生素D水平 |
| WO2018188771A1 (en) | 2017-04-11 | 2018-10-18 | Nestec S.A. | Omega-3 fatty acid and vitamin d levels to identify and attenuate cognitive aging in individuals |
| IL296055A (en) | 2017-08-14 | 2022-10-01 | Axcella Health Inc | Amino acid compositions for the treatment of liver disease |
| MA52971A (fr) | 2018-06-20 | 2021-04-28 | Axcella Health Inc | Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle |
| US12264333B2 (en) | 2018-09-20 | 2025-04-01 | Mystem Biotechnologies Inc. | Colostrum derived stem cells, neural differentiation, compositions and supplements for enhancing mammalian health |
| CN110801007A (zh) * | 2019-12-17 | 2020-02-18 | 苟春虎 | 老年肌少症营养肽 |
| JP2021165235A (ja) * | 2020-04-06 | 2021-10-14 | 株式会社ファンケル | アトロジン−１発現抑制剤 |
| US20220062344A1 (en) * | 2020-09-03 | 2022-03-03 | Société des Produits Nestlé S.A. | Compositions and methods for providing health benefits in an animal |
| CN118891052A (zh) * | 2021-12-09 | 2024-11-01 | 雀巢产品有限公司 | 用以增加微生物群的胍丁胺产生的嗜酸乳杆菌 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5952033A (en) | 1996-12-24 | 1999-09-14 | Nestec S.A. | Gelatinized cereal product containing oligosaccharide and processes of preparing and using same |
| DE69707413T3 (de) | 1997-01-09 | 2009-07-02 | Société des Produits Nestlé S.A. | Probiotik enthaltendes Getreideprodukt |
| AUPP327198A0 (en) * | 1998-04-30 | 1998-05-21 | Northfield Laboratories Pty Ltd | A food composition and method of using same |
| US20020068365A1 (en) * | 1998-07-28 | 2002-06-06 | Eric H. Kuhrts | Controlled release nitric oxide producing agents |
| PE20010526A1 (es) | 1999-09-07 | 2001-05-22 | Nestle Sa | Composicion a base de prebioticos para mejorar la piel y el pelaje de animales domesticos |
| RU2254772C2 (ru) | 1999-09-22 | 2005-06-27 | Сосьете Де Продюи Нестле С.А. | Способ повышения активности стареющего домашнего животного |
| EP1290136B1 (en) | 2000-05-25 | 2006-05-10 | Société des Produits Nestlé S.A. | Probiotics for pet food applications |
| ES2269406T3 (es) | 2000-05-26 | 2007-04-01 | Societe Des Produits Nestle S.A. | Producto alimenticio para animales domesticos. |
| WO2002047612A2 (en) * | 2000-10-27 | 2002-06-20 | Mannatech, Inc. | Dietary supplement compositions |
| US8669282B2 (en) * | 2000-10-31 | 2014-03-11 | Hill's Pet Nutrition, Inc. | Companion animal compositions including lipoic acid and methods of use thereof |
| GB0027761D0 (en) | 2000-11-14 | 2000-12-27 | Nestle Sa | Nutritional composition for an immune condition |
| US20060014773A1 (en) * | 2001-04-19 | 2006-01-19 | Mccleary Edward L | Mental agility lozenge, edible strip, food or drink |
| US20040166206A1 (en) * | 2003-02-25 | 2004-08-26 | Archibald William E. | Vacuum packaged food products and methods of making same |
| EP1344458A1 (en) | 2002-03-12 | 2003-09-17 | Société des Produits Nestlé S.A. | Probiotic delivery system |
| EP1919304B1 (en) * | 2005-08-26 | 2011-05-25 | Nestec S.A. | Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis after an ischemic episode in the brain |
| WO2007049796A2 (en) * | 2005-10-26 | 2007-05-03 | Kao Corporation | Resveratrol and/or grape leaf extract as i. a. endurance improver, anti-aging agent, muscle strength improver |
| DK1800675T3 (da) | 2005-12-23 | 2011-09-05 | Nutricia Nv | Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens |
| JP5264702B2 (ja) | 2006-03-29 | 2013-08-14 | ネステク ソシエテ アノニム | プロバイオティクスを含有する栄養補助食品 |
| JP2008189585A (ja) * | 2007-02-02 | 2008-08-21 | Qualicaps Co Ltd | 水溶性硬質カプセル剤 |
| JP2008214338A (ja) * | 2007-02-08 | 2008-09-18 | Shiseido Co Ltd | 高次脳機能低下改善剤および遅延記憶低下改善剤 |
| FR2913885B1 (fr) * | 2007-03-22 | 2012-07-20 | Univ Paris Descartes | Utilisation de la citrulline pour le traitement des pathologies liees a une augmentation de la carbonylation des proteines |
| ES2664777T5 (es) * | 2007-10-04 | 2021-10-25 | Nestle Sa | Composiciones y procedimientos para mejorar la función cognitiva |
| CA2994586C (en) * | 2008-01-04 | 2020-07-21 | Nestec S.A. | Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions |
| US20100056484A1 (en) | 2008-08-26 | 2010-03-04 | Scott Farese | Dietary supplemental composition effective for enhancing cognitive performance, elevating mood and reducing oxidative stress |
| CN101433241A (zh) * | 2008-12-05 | 2009-05-20 | 江苏星驰生物科技有限公司 | 配方牛初乳 |
| WO2010095926A1 (en) * | 2009-02-20 | 2010-08-26 | N.V. Nutricia | Use of reveratrol for preserving cognitive functioning |
| JP5606004B2 (ja) * | 2009-03-31 | 2014-10-15 | 小林製薬株式会社 | 血中アルブミン量の増加促進または減少抑制用組成物 |
-
2012
- 2012-03-12 JP JP2013558083A patent/JP2014515011A/ja active Pending
- 2012-03-12 RU RU2013146517/15A patent/RU2600893C2/ru active
- 2012-03-12 WO PCT/US2012/028712 patent/WO2012128982A2/en not_active Ceased
- 2012-03-12 EP EP12760637.4A patent/EP2685987B1/en active Active
- 2012-03-12 ES ES12760637T patent/ES2727043T3/es active Active
- 2012-03-12 BR BR112013023770-8A patent/BR112013023770B1/pt active IP Right Grant
- 2012-03-12 MX MX2013010680A patent/MX359453B/es active IP Right Grant
- 2012-03-12 CN CN201280022679.3A patent/CN104066342A/zh active Pending
- 2012-03-12 US US14/004,947 patent/US10010566B2/en active Active
- 2012-03-12 CA CA2830476A patent/CA2830476C/en active Active
- 2012-03-12 AU AU2012231351A patent/AU2012231351B2/en active Active
-
2013
- 2013-10-17 ZA ZA2013/07770A patent/ZA201307770B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014515011A5 (https=) | ||
| RU2013146517A (ru) | Композиции и способы, пригодные для облегчения возрастных заболеваний | |
| Chikwanha et al. | Nutritional enhancement of sheep meat fatty acid profile for human health and wellbeing | |
| JP2010540636A5 (https=) | ||
| JP2015147773A5 (https=) | ||
| JP2020503036A5 (https=) | ||
| JP2011508773A5 (https=) | ||
| JP2016041705A5 (https=) | ||
| PH12018500090A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| WO2011097273A8 (en) | Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl l-cysteine | |
| BR112014009097A2 (pt) | composição para uso na promoção de crescimento de osso saudável e/ou na prevenção e/ou tratamento das doenças dos ossos | |
| JP2010519317A5 (https=) | ||
| GB2459809A (en) | Fatty acid formulations and methods of use thereof | |
| JP2014505702A5 (https=) | ||
| NZ611606A (en) | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity | |
| JP2010518867A5 (https=) | ||
| JP2013515781A5 (https=) | ||
| PH12018500035A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| BR112012017690A2 (pt) | Emulsões nutricionais compreendendo hmb de cálcio | |
| BR112018072064B8 (pt) | Uso de triglicerídeos de cadeia média para preparação de composições nutricionais para proteção cardíaca em animais de estimação | |
| JP2014514248A5 (https=) | ||
| JP2017538402A5 (https=) | ||
| BR112015032572A2 (pt) | composições e métodos para melhorar o desempenho durante exercícios | |
| BR112013027474A2 (pt) | composições que melhoram a palatabilidade | |
| MX2013006094A (es) | Metodo para inhibir patogenos usando composicion nutricional. |